Correlation Between Conduit Pharmaceuticals and Altria

Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Altria at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Altria into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Conduit Pharmaceuticals and Altria Group, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Altria and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Altria. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Altria.

Diversification Opportunities for Conduit Pharmaceuticals and Altria

0.52

Correlation Coefficient

Conduit Pharmaceuticals  Altria

Very weak diversification

The 3 months correlation between Conduit and Altria is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Altria Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altria Group and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Altria. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altria Group has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Altria go up and down completely randomly.

Pair Corralation between Conduit Pharmaceuticals and Altria

Considering the 90-day investment horizon Conduit Pharmaceuticals is expected to generate 19.04 times more return on investment than Altria. However, Conduit Pharmaceuticals is 19.04 times more volatile than Altria Group. It trades about 0.03 of its potential returns per unit of risk. Altria Group is currently generating about -0.15 per unit of risk. If you would invest  5.82  in Conduit Pharmaceuticals on October 27, 2024 and sell it today you would lose (0.82) from holding Conduit Pharmaceuticals or give up 14.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Conduit Pharmaceuticals  vs.  Altria Group

Conduit Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Conduit Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Altria Group

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Altria Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Altria is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Conduit Pharmaceuticals and Altria

The main advantage of trading using opposite Conduit Pharmaceuticals and Altria positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Altria can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altria will offset losses from the drop in Altria's long position.

The idea behind Conduit Pharmaceuticals and Altria Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.